Filing Details
- Accession Number:
- 0001214659-25-004753
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-25 16:30:09
- Reporting Period:
- 2025-03-21
- Filing Date:
- 2025-03-25
- Accepted Time:
- 2025-03-25 16:30:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
791908 | Xoma Royalty Corp | XOMA | Pharmaceutical Preparations (2834) | 522154066 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1959809 | Bradley Sitko | C/O Xoma Royalty Corporation 2200 Powell Street, Suite 310 Emeryville CA 94608 | Chief Investment Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-03-21 | 1,334 | $20.65 | 10,484 | No | 4 | P | Direct | |
Depositary Shares - 8.375% B Cumulative Stock | Acquisiton | 2025-03-21 | 2,800 | $25.43 | 2,800 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
8.625% Series A Cumulative Perpetual Preferred Stock | 313 | Direct | |
Common Stock | 829 | Indirect | By 401(k) |
Common Stock | 1,500 | Indirect | By spouse |
Common Stock | 75 | Indirect | By child |
Common Stock | 75 | Indirect | By child |
8.625% Series A Cumulative Perpetual Preferred Stock | 82 | Indirect | By spouse |
Depositary Shares - 8.375% B Cumulative Stock | 2,000 | Indirect | By spouse |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $20.60 to $20.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $25.42 to $25.46. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.